Solid Biosciences (SLDB) Short Interest Ratio & Short Volume → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free SLDB Stock Alerts $10.34 +0.09 (+0.88%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Solid Biosciences Short Interest DataCurrent Short Volume1,050,000 sharesPrevious Short Volume920,900 sharesChange Vs. Previous Month+14.02%Dollar Volume Sold Short$10.50 millionShort Interest Ratio / Days to Cover4.0Last Record DateApril 15, 2024Outstanding Shares37,861,000 sharesFloat Size30,250,000 sharesShort Percent of Float3.47%Today's Trading Volume67,598 sharesAverage Trading Volume312,863 sharesToday's Volume Vs. Average22% Short Selling Solid Biosciences ? Sign up to receive the latest short interest report for Solid Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSLDB Short Interest Over TimeSLDB Days to Cover Over TimeSLDB Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details Solid Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,050,000 shares $10.50 million +14.0%3.5%4 $10.00 3/31/2024920,900 shares $12.27 million +49.8%3.1%2.5 $13.32 3/15/2024614,900 shares $8.04 million -3.0%2.0%1.8 $13.08 2/29/2024633,600 shares $5.95 million +4.3%2.1%1.3 $9.39 2/15/2024607,300 shares $5.97 million +41.8%2.0%1.3 $9.83 1/31/2024428,300 shares $2.95 million +11.5%1.8%0.6 $6.89 Get the Latest News and Ratings for SLDB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Solid Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024384,000 shares $2.96 million +55.0%2.8%0.6 $7.71 12/31/2023247,800 shares $1.52 million +21.8%1.5%0.4 $6.14 12/15/2023203,400 shares $1.06 million -6.4%1.2%0.4 $5.19 11/30/2023217,200 shares $612,504.00 +508.4%1.3%0.5 $2.82 11/15/202335,700 shares $97,282.50 -5.8%0.2%0.1 $2.73 10/31/202337,900 shares $84,517.00 +76.3%0.2%1.4 $2.23 10/15/202321,500 shares $46,440.00 -27.4%0.1%0.9 $2.16 9/30/202329,600 shares $74,592.00 -0.3%0.2%2 $2.52 9/15/202329,700 shares $92,664.00 -1.3%0.2%2.3 $3.12 8/31/202330,100 shares $108,661.00 -30.0%0.2%1.4 $3.61 8/15/202343,000 shares $161,465.00 +24.6%0.3%2.1 $3.76 7/31/202334,500 shares $148,695.00 -20.0%0.2%1.6 $4.31 7/15/202343,100 shares $211,625.31 -1.4%0.3%1.7 $4.91 6/30/202343,700 shares $228,988.00 +7.1%0.3%1.6 $5.24 6/15/202340,800 shares $255,408.00 +60.0%0.3%1.3 $6.26 5/31/202325,500 shares $157,590.00 -37.4%0.2%0.8 $6.18 5/15/202340,700 shares $254,375.00 +5.4%0.3%1.2 $6.25 4/30/202338,600 shares $188,368.00 -14.2%0.3%1.1 $4.88 4/15/202345,000 shares $228,150.00 +24.7%0.3%1.2 $5.07 3/31/202336,100 shares $171,114.00 +71.9%0.2%1 $4.74 3/15/202321,000 shares $100,800.00 +62.8%0.1%0.6 $4.80 2/28/202312,900 shares $72,498.00 -6.5%0.1%0.5 $5.62 2/15/202313,800 shares $92,598.00 -85.2%0.1%0.5 $6.71 1/31/202393,200 shares $706,456.00 +162.5%1.0%3.3 $7.58 1/15/202335,500 shares $239,625.00 -36.2%0.4%1.1 $6.75 12/30/202255,600 shares $299,128.00 -27.8%0.6%1.8 $5.38 12/15/202277,000 shares $527,450.00 -21.5%2.1%2.3 $6.85 11/30/202298,100 shares $657,270.00 -11.1%1.6%3.1 $6.70 11/15/2022110,400 shares $734,160.00 +69.1%1.8%3.7 $6.65 10/31/202265,300 shares $418,573.00 -91.3%1.0%2 $6.41 10/15/2022749,700 shares $342,088.11 +10.7%0.8%1.9 $0.46 9/30/2022677,300 shares $316,028.18 -2.6%0.8%1.7 $0.47 9/15/2022695,500 shares $443,311.70 +59.8%0.8%1.3 $0.64 8/31/2022435,200 shares $278,528.00 -17.2%0.5%0.7 $0.64The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him SLDB Short Interest - Frequently Asked Questions What is Solid Biosciences' current short interest? Short interest is the volume of Solid Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,050,000 shares of SLDB short. 3.47% of Solid Biosciences' shares are currently sold short. Learn More on Solid Biosciences' current short interest. What is a good short interest ratio for Solid Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLDB shares currently have a short interest ratio of 4.0. Learn More on Solid Biosciences's short interest ratio. What is a good short interest percentage for Solid Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.47% of Solid Biosciences' floating shares are currently sold short. Is Solid Biosciences' short interest increasing or decreasing? Solid Biosciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,050,000 shares, an increase of 14.0% from the previous total of 920,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Solid Biosciences' float size? Solid Biosciences currently has issued a total of 37,861,000 shares. Some of Solid Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Solid Biosciences currently has a public float of 30,250,000 shares. How does Solid Biosciences' short interest compare to its competitors? 3.47% of Solid Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Solid Biosciences: Ocugen, Inc. (17.58%), Tourmaline Bio, Inc. (11.58%), Black Diamond Therapeutics, Inc. (3.35%), TScan Therapeutics, Inc. (1.09%), Aura Biosciences, Inc. (6.50%), Replimune Group, Inc. (18.75%), Tenaya Therapeutics, Inc. (5.41%), Fate Therapeutics, Inc. (16.62%), Lexeo Therapeutics, Inc. (5.21%), iTeos Therapeutics, Inc. (7.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Solid Biosciences stock? Short selling SLDB is an investing strategy that aims to generate trading profit from Solid Biosciences as its price is falling. SLDB shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Solid Biosciences? A short squeeze for Solid Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLDB, which in turn drives the price of the stock up even further. How often is Solid Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLDB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OCGN Short Interest TRML Short Interest BDTX Short Interest TCRX Short Interest AURA Short Interest REPL Short Interest TNYA Short Interest FATE Short Interest LXEO Short Interest ITOS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLDB) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research